Skip to main
AMN
AMN logo

AMN Stock Forecast & Price Target

AMN Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 57%
Hold 14%
Sell 14%
Strong Sell 0%

Bulls say

AMN Healthcare Services reported 2Q25 revenue of $658.2 million, which, despite being an 11% year-over-year decline, surpassed both internal estimates and consensus expectations. The company's gross margin improved to 29.8%, exceeding its guidance range, and reflecting a sequential increase of 120 basis points. Additionally, AMN has demonstrated a consistent ability to outperform expectations, with an average revenue surprise of 3% and an EBITDA surprise of 12% over the past four quarters, contributing to a positive outlook for the stock.

Bears say

AMN Healthcare Services Inc reported a significant decline in segment revenues, with the nurse and allied solutions segment experiencing a 9% year-over-year decrease, and the physician and leadership solutions segment reflecting a substantial 14% decline year-over-year. The overall operating margin also contracted, declining by 30 basis points quarter-over-quarter to 7.5%, raising concerns about profitability. Additionally, a notable 31% year-over-year drop in Vendor Management System (VMS) revenue further underscores challenges within the company’s core operations, despite a slight increase in language services revenue.

AMN has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 57% recommend Buy, 14% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMN Healthcare Services (AMN) Forecast

Analysts have given AMN a Buy based on their latest research and market trends.

According to 7 analysts, AMN has a Buy consensus rating as of Dec 13, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $23.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $23.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMN Healthcare Services (AMN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.